Volumetric Contrast‐Enhanced Ultrasound Imaging to Assess Early Response to Apoptosis‐Inducing Anti–Death Receptor 5 Antibody Therapy in a Breast Cancer Animal Model

The objective of this study was to determine whether volumetric contrast‐enhanced ultrasound (US) imaging could detect early tumor response to anti–death receptor 5 antibody (TRA‐8) therapy alone or in combination with chemotherapy in a preclinical triple‐negative breast cancer animal model.

[1]  Kenneth Hoyt,et al.  Determination of Breast Cancer Response to Bevacizumab Therapy Using Contrast‐Enhanced Ultrasound and Artificial Neural Networks , 2010, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[2]  Linda Chami,et al.  Dynamic contrast-enhanced ultrasonography (DCE-US) and anti-angiogenic treatments. , 2011, Discovery medicine.

[3]  William E Grizzle,et al.  Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. , 2008, Radiology.

[4]  Olivier Lucidarme,et al.  Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model. , 2006, Radiology.

[5]  A. Winoto,et al.  FADD Is Required for DR4- and DR5-mediated Apoptosis , 2000, The Journal of Biological Chemistry.

[6]  Paul A Dayton,et al.  Quantitative Volumetric Perfusion Mapping of the Microvasculature Using Contrast Ultrasound , 2010, Investigative radiology.

[7]  L. Hood,et al.  Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. , 1997, Immunity.

[8]  B. Goldberg,et al.  Contrast enhanced maximum intensity projection ultrasound imaging for assessing angiogenesis in murine glioma and breast tumor models: A comparative study. , 2011, Ultrasonics.

[9]  Sanjiv S Gambhir,et al.  Targeted microbubbles for imaging tumor angiogenesis: assessment of whole-body biodistribution with dynamic micro-PET in mice. , 2008, Radiology.

[10]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[11]  D. Fishman,et al.  Advances in sonographic detection of ovarian cancer: depiction of tumor neovascularity with microbubbles. , 2010, AJR. American journal of roentgenology.

[12]  Linda Chami,et al.  Advanced hepatocellular carcinoma: early evaluation of response to bevacizumab therapy at dynamic contrast-enhanced US with quantification--preliminary results. , 2011, Radiology.

[13]  K. Hoyt,et al.  Quantitative Mapping of Tumor Vascularity Using Volumetric Contrast-Enhanced Ultrasound , 2011, Investigative radiology.

[14]  Panagiotis Samaras,et al.  Quantitative Perfusion Analysis of Malignant Liver Tumors: Dynamic Computed Tomography and Contrast-Enhanced Ultrasound , 2012, Investigative radiology.

[15]  D. Buchsbaum,et al.  Mechanisms of Drug Sensitization to TRA-8, an Agonistic Death Receptor 5 Antibody, Involve Modulation of the Intrinsic Apoptotic Pathway in Human Breast Cancer Cells , 2011, Molecular Cancer Research.

[16]  Zhi Huang,et al.  TRA-8 anti-DR5 monoclonal antibody and gemcitabine induce apoptosis and inhibit radiologically validated orthotopic pancreatic tumor growth , 2007, Molecular Cancer Therapeutics.

[17]  Henning Walczak,et al.  TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL , 1997, The EMBO journal.

[18]  J. Denekamp,et al.  Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. , 1993, The British journal of radiology.

[19]  William E. Grizzle,et al.  DCE-MRI Detects Early Vascular Response in Breast Tumor Xenografts Following Anti-DR5 Therapy , 2011, Molecular Imaging and Biology.

[20]  E. Leen,et al.  Assessment of Global Liver Blood Flow With Quantitative Dynamic Contrast‐Enhanced Ultrasound , 2011, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[21]  Sanjiv S Gambhir,et al.  US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice. , 2008, Radiology.

[22]  Tae Kyoung Kim,et al.  Hypervascular liver masses on contrast-enhanced ultrasound: the importance of washout. , 2010, AJR. American journal of roentgenology.

[23]  Sanjiv S. Gambhir,et al.  Targeted Contrast-Enhanced Ultrasound Imaging of Tumor Angiogenesis with Contrast Microbubbles Conjugated to Integrin-Binding Knottin Peptides , 2010, Journal of Nuclear Medicine.

[24]  C. Perou,et al.  Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. , 2006, JAMA.

[25]  J. Denekamp,et al.  Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy , 1993 .

[26]  D. Buchsbaum,et al.  TRAIL receptor-targeted therapy. , 2006, Future oncology.

[27]  R. Ponzone,et al.  Variation of breast vascular maps on dynamic contrast-enhanced MRI after primary chemotherapy of locally advanced breast cancer. , 2011, AJR. American journal of roentgenology.

[28]  Sanjiv S Gambhir,et al.  Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55). , 2010, Radiology.

[29]  F. Stuart Foster,et al.  Microultrasound Molecular Imaging of Vascular Endothelial Growth Factor Receptor 2 in a Mouse Model of Tumor Angiogenesis , 2007, Molecular imaging.

[30]  William E Grizzle,et al.  Antitumor efficacy of TRA-8 anti-DR5 monoclonal antibody alone or in combination with chemotherapy and/or radiation therapy in a human breast cancer model. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[31]  Kumar Sharma,et al.  Ultrasound Molecular Imaging of Tumor Angiogenesis With an Integrin Targeted Microbubble Contrast Agent , 2011, Investigative radiology.